- Home
- usa massachusetts
- Companies
Refine by
Medical Industry Technology In Usa Massachusetts
35 companies found
Technologybased inBoston, MASSACHUSETTS (USA)
We can create human tissues and organs using cells from our own bodies, paving the way to make us our own organ donors, reducing organ rejection and solve the problem with lack of donors. We can save lives with faster and more accurate methods for ...
Enabling high-throughput 3D cell culturing and bioprinting to create the future of health. The epitome of user-friendly flexibility. Bioprint with more materials for even more complex models. Independent dual pressure that enables coaxial and mixing ...
Technologybased inCambridge, MASSACHUSETTS (USA)
Iterative Health is pioneering the use of artificial intelligence-based precision medicine in gastroenterology (GI), with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD) and improving the ...
Hands-on support throughout the trial process. Our Professional Services team stays fully engaged, even after AI-R implementation. We continue to provide valuable support for the full life cycle of any clinical research ...
Technologybased inHolliston, MASSACHUSETTS (USA)
HRGN is a clinical-stage biotechnology company that uses a patient’s own stem cells that are grown on a hollow tubular scaffold to regenerate organ tissue damaged from cancer, trauma, birth defects or other diseases. The patient’s stem ...
Cellspan Bronchial Implants may enable the surgeon to preserve the lung and repair the bronchus following surgical resection—without debilitating outcomes and ...
Technologybased inDanvers, MASSACHUSETTS (USA)
Abiomed is a leading provider of groundbreaking medical technology that provides circulatory and oxygenation support. The Impella® heart pump platform is designed to enable the heart to rest and recover by improving blood flow and/or temporarily ...
A heart pump designed for surgeons with forward flow and intelligent patient management. Impella 5.5 with SmartAssist delivers full cardiac support with maximum unloading, allowing the heart to rest and recover. It is a microaxial, surgically ...
Technologybased inBoston, MASSACHUSETTS (USA)
People living with rare and devastating diseases are our Guiding Star. We believe it is our responsibility to listen to, understand, and change the lives of patients and those who work tirelessly to help them. Our mission is to transform the lives ...
Our innovation is driven by a sense of urgency and a relentless quest for answers, because lives are at stake. Through research and development we’re building a better tomorrow, every ...
Technologybased inWoburn, MASSACHUSETTS (USA)
Aegle Therapeutics is a first in class, phase 1/2a stage biotechnology company isolating extracellular vesicles including exosomes (EVs) secreted by allogeneic bone marrow derived mesenchymal stem cells to treat dystrophic epidermolysis bullosa ...
Epidermolysis bullosa (“EB”) is a group of rare genetic disorders that manifests as blistering or erosion of the skin in response to little or no apparent trauma. There are many genetic and symptomatic variations of EB. EB is always ...
Technologybased inCambridge, MASSACHUSETTS (USA)
Founded in 2018 by a team of accomplished scientists with a proven track record in drug discovery and executive leadership in top global biopharmaceutical companies, Regor is a pioneering international biotech company with headquarters in Shanghai, ...
rCARD™, Computer Accelerated Rational Discovery, is a powerful and proprietary technology platform currently under development at Regor. We have hired a team of experienced computational chemists and structural biologists trained at ...
Technologybased inCambridge, MASSACHUSETTS (USA)
mRNA gives scientists superpowers. Technology finds information and delivers physical products to us almost instantly. mRNA does the same for biology. At HelixNano, we see a world where treatments are cheap, progress is decentralized, and you can ...
Technologybased inMaynard, MASSACHUSETTS (USA)
NorthEast Monitoring is committed to advancing Holter technology with our innovative ambulatory cardiac hardware and software solutions. We created the world’s FIRST 14-DAY Holter and event recorder, provide flexible licensing models for our ...
Technologybased inCambridge, MASSACHUSETTS (USA)
Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, Cancer ...
Immunotherapeutic cancer vaccines have generated a lot of interest from oncologists since it was discovered that immune activation can lead to a specific antitumor response.1 However, despite initial progress, most cancer vaccines have failed to ...
Technologybased inLexington, MASSACHUSETTS (USA)
OnPoint Surgical is revolutionizing orthopedic and neurosurgical spinal procedures with an Augmented Reality (AR) platform technology that superimposes virtual surgical guides and virtual spinal implants onto the surgeon’s visual field using ...
OnPoint’s Intellectual Property includes a broad range of granted patents and patent applications for Augmented Reality guidance of spinal, neurosurgical, and other surgical procedures. ...
Technologybased inParis, FRANCE
TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: To reconstruct damaged tissue and restore its natural function. Our mission is to disrupt the field of surgery and ...
Our proprietary biomorphic programmable polymers enable tissue reconstruction and can be adapted for use in multiple clinical ...
Technologybased inBoston, MASSACHUSETTS (USA)
Like our customers and their consumers, we needed a real change in the probiotic world that would result in products with benefits we can all feel. We knew current probiotics on the market deliver unpredictable benefits for some people, while not ...
Yso3 is a preclinical drug development program aimed at treating asthma. Using a revolutionary form of living biotherapy targeting the lung, YSOPIA is pioneering the innovative field of the lung microbiome. As part of this program, YSOPIA has ...
Technologybased inLexington, MASSACHUSETTS (USA)
At T2 Biosystems, our mission is to save lives and improve healthcare by empowering clinicians to get patients on the right therapy faster. We come to work every day to solve critical needs in healthcare diagnostics with innovative solutions built ...
The T2SARS-CoV-2 Panel, run on the T2Dx® Instrument, is a qualitative reverse transcriptase-polymerase chain reaction (RT-PCR) and T2 Magnetic Resonance (T2MR®) test. This test is designed for the direct detection of nucleic acid from ...
Technologybased inCambridge, MASSACHUSETTS (USA)
We are a cell therapy company that combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. Vor, the Norse goddess of wisdom, was known as the careful one. ...
Our first multi-targeted Treatment System is comprised of VOR33-CLL1 multiplex-edited eHSC therapy and VCAR33-CLL1 multi-specific CAR-T therapy. Knocking out CD33 and CLL-1 through gene editing offers a promising new approach to treating patients ...
Technologybased inFramingham, MASSACHUSETTS (USA)
Kephera Diagnostics is a startup that aims to address the public health challenges of global infectious diseases with point of care assay technology. We collaborate with a global community of researchers to develop and translate new technologies ...
With support from a National Institutes of Health grant, Kephera is developing a new point-of-care test for Chagas disease. Kephera scientists have identified and are purifying parasite components which promise to yield a highly sensitive and ...
Technologybased inMilano, ITALY
InnovHeart, with locations in Milan, Italy, and Boston, Massachusetts, develops transcatheter mitral valve replacement (TMVR) systems to treat patients suffering from mitral valve disease. The company is currently in clinical trials testing its ...
The Mitral Valve is a complex structure positioned between the left atrium and the left ventricle. Its function is to make unidirectional the blood flow from the left atrium to the left ventricle. The Mitral Valve can be affected by two major ...
Technologybased inCambridge, MASSACHUSETTS (USA)
Myeloid Therapeutics is a leader in the development of mRNA-based immunotherapies, focusing on harnessing and enhancing the natural capabilities of myeloid cells to combat cancer. The company's cutting-edge in vivo engineering platform is designed ...
Myeloid is focused on advancing its ATAK CAR monocytes, which are myeloid cells with innate immune receptor-inspired CARs to recognize and kill cancer. Additionally, Myeloid has streamlined manufacturing for its ATAK cell therapy candidates through ...
Technologybased inGaithersburg, MASSACHUSETTS (USA)
In November 2023, Selecta Biosciences Inc. (NASDAQ: SELB) merged with Cartesian Therapeutics to create a publicly traded company pioneering RNA cell therapy to treat autoimmune disease. The combined company will focus on advancing Cartesian’s wholly ...
Selecta’s first ImmTORTM + gene therapy candidate MMA-101 for methylmalonic acidemia (MMA) is expected to enter clinical trials the end of 2021. MMA is a rare metabolic disease that may lead to metabolic acidosis and hyperammonemia and is ...
Technologybased inCambridge, MASSACHUSETTS (USA)
Vaxxas is commercializing novel technology that dramatically enhances the performance of existing and next-generation vaccines. The company believes its innovative needle-free technology will be fundamental to help the world in rethinking what's ...
Vaxxas is commercializing a novel vaccination technology that dramatically enhances the performance of existing and next-generation vaccines. The core of Vaxxas technology platform is a High Density Microarray Patch (HD-MAP). Vaxxas' HD-MAP is ...